Could the Neutrophil to Lymphocyte Ratio be a Poor Prognostic Factor for Non Small Cell Lung Cancers?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Could the Neutrophil to Lymphocyte Ratio be a Poor Prognostic Factor for Non Small Cell Lung Cancers?
Authors
Keywords
-
Journal
Asian Pacific Journal of Cancer Prevention
Volume 15, Issue 5, Pages 2089-2094
Publisher
Asian Pacific Organization for Cancer Prevention
Online
2014-07-10
DOI
10.7314/apjcp.2014.15.5.2089
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic Significance of Basic Laboratory Methods in Non-Small-Cell-Lung Cancer
- (2014) Vildan Kaya et al. Asian Pacific Journal of Cancer Prevention
- Survival Analysis and Prognostic Factors for Neuroendocrine Tumors in Turkey
- (2014) Birsen Yucel et al. Asian Pacific Journal of Cancer Prevention
- Are Neutrophil/Lymphocyte and Platelet/Lymphocyte Rates in Patients with Non-Small Cell Lung Cancer Associated with Treatment Response and Prognosis?
- (2014) Dilek Unal et al. Asian Pacific Journal of Cancer Prevention
- The Blood Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib
- (2014) You-Bing Zheng et al. Asian Pacific Journal of Cancer Prevention
- Preoperative Neutrophil-to-Lymphocyte Ratio Is a Predictor of Survival After Hepatectomy for Hepatocellular Carcinoma
- (2013) Yohei Mano et al. ANNALS OF SURGERY
- Prognostic and Predictive Value of Hematologic Parameters in Patients with Metastatic Renal Cell Carcinoma: Second Line Sunitinib Treatment Following IFN-alpha
- (2013) Ahmet Dirican et al. Asian Pacific Journal of Cancer Prevention
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
- (2012) Yanwen Yao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer
- (2012) S. Cedrés et al. Clinical & Translational Oncology
- Distinct Clinical Course of EGFR -Mutant Resected Lung Cancers: Results of Testing of 1118 Surgical Specimens and Effects of Adjuvant Gefitinib and Erlotinib
- (2012) Sandra P. D’Angelo et al. Journal of Thoracic Oncology
- Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer
- (2012) Jian Zhang et al. MEDICAL ONCOLOGY
- Association of Nutrition Parameters Including Bioelectrical Impedance and Systemic Inflammatory Response With Quality of Life and Prognosis in Patients With Advanced Non-Small-Cell Lung Cancer: A Prospective Study
- (2012) Karla Sánchez-Lara et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Evaluation and Management of Elderly Patients With Lung Cancer
- (2012) Elizabeth Gore et al. SEMINARS IN RADIATION ONCOLOGY
- Prognostic Value of Neutrophil-to-lymphocyte Ratio and Establishment of Novel Preoperative Risk Stratification Model in Bladder Cancer Patients Treated With Radical Cystectomy
- (2012) Tatsuo Gondo et al. UROLOGY
- Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
- (2011) W Chua et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer
- (2011) T. A. Zikos et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer
- (2010) Tom Donnem et al. CANCER
- High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy
- (2010) S. C. H. Kao et al. CLINICAL CANCER RESEARCH
- Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene
- (2009) Tsuyoshi Takahashi et al. ANNALS OF SURGICAL ONCOLOGY
- Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03
- (2009) Satoshi Teramukai et al. EUROPEAN JOURNAL OF CANCER
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
- (2009) Campbell SD Roxburgh et al. Future Oncology
- Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
- (2009) Kathy S Albain et al. LANCET
- Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer
- (2008) Khaled M. Sarraf et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started